Low concentration of oxidized low-density lipoprotein and lysophosphatidylcholine upregulate constitutive nitric oxide synthase mRNA expression in bovine aortic endothelial cells

Circulation Research
K HirataM Yokoyama

Abstract

Endothelium-dependent relaxation is markedly reduced in atherosclerotic arteries. Recently, the endothelium-dependent relaxing factor has been identified as nitric oxide (NO). We used RNase protection assay and immunoblotting to elucidate the effect of atherogenic lipoprotein on the expression of constitutive NO synthase (cNOS) mRNA and protein levels in bovine aortic endothelial cells. Twenty-four-hour exposure to a low concentration of oxidized low-density lipoprotein (10 micrograms protein/mL) upregulated cNOS mRNA levels (2.4 +/- 0.4-fold, P < .01). However, native low-density lipoprotein and high-density lipoprotein did not have any effect on cNOS mRNA levels. Furthermore, 5 micrograms/mL of lysophosphatidylcholine (LPC) also upregulated cNOS mRNA levels (2.6 +/- 0.5-fold, P < .01) at 8 hours. This action of LPC was abolished with cycloheximide but not with staurosporine. We concluded that atherogenic lipoproteins upregulate cNOS mRNA and protein levels in bovine aortic endothelial cells. This observation supports the hypothesis that an impairment of endothelium-dependent vasodilatation in atherosclerotic vessels may not be due to a decrease in cNOS expression. Moreover, the LPC action on cNOS mRNA levels requires new prot...Continue Reading

References

May 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·W T ShierN M Thanassi
Jan 1, 1978·Tissue & Cell·U S RyanJ W Ryan
Jul 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·S LamasT Michel
Jul 31, 1992·Biochemical and Biophysical Research Communications·N Miki, T Tokuhisa
May 1, 1990·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·M E RosenfeldJ L Witztum
Dec 1, 1990·The Journal of Clinical Investigation·R L MinorD G Harrison
Apr 6, 1989·The New England Journal of Medicine·D SteinbergJ L Witztum
Oct 1, 1989·The Journal of Clinical Investigation·S Ylä-HerttualaD Steinberg
Nov 4, 1986·European Journal of Pharmacology·G WeinheimerH Osswald
Jun 4, 1987·European Journal of Pharmacology·M J Lewis, A H Henderson
Apr 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·M T QuinnD Steinberg
Aug 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·T KitaC Kawai
Jan 1, 1987·Cardiovascular Research·S P ChappellA H Henderson
Jun 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·U P SteinbrecherD Steinberg
Sep 1, 1955·The Journal of Clinical Investigation·R J HAVELJ H BRAGDON

❮ Previous
Next ❯

Citations

Feb 24, 2000·The Journal of Pathology·H Li, U Förstermann
Mar 15, 1996·Journal of the American College of Cardiology·S HoshidaM Tada
Mar 6, 1997·The American Journal of Cardiology·A P SelwynP Ganz
May 3, 2002·Journal of the American College of Cardiology·Jawahar L Mehta, Dayuan Li
Feb 13, 2001·Free Radical Biology & Medicine·P MorielD S Abdalla
Oct 17, 2002·Nitric Oxide : Biology and Chemistry·Huige LiUlrich Förstermann
Sep 12, 2002·Nitric Oxide : Biology and Chemistry·Huige LiUlrich Förstermann
Dec 1, 2006·Preparative Biochemistry & Biotechnology·Tsuyoshi SakodaMitsumasa Ohyanagi
Apr 30, 2003·Antioxidants & Redox Signaling·Shane R ThomasJohn F Keaney
Aug 19, 2008·Antioxidants & Redox Signaling·Shane R ThomasGrant R Drummond
Dec 24, 1997·Clinical and Experimental Pharmacology & Physiology·S W LeungR Y Man
Jan 13, 2006·Annual Review of Pharmacology and Toxicology·David M DudzinskiThomas Michel
Dec 31, 1997·The Journal of Clinical Investigation·D G Harrison
Mar 13, 2001·Biochemical and Biophysical Research Communications·Y RikitakeM Yokoyama
Sep 15, 1998·Free Radical Research·K R Bruckdorfer
Aug 30, 2008·Journal of the American College of Surgeons·Christina L Huang, Bauer E Sumpio
Sep 27, 2003·Diabetic Medicine : a Journal of the British Diabetic Association·O KonopatskayaA C Shore
Dec 21, 2010·Microcirculation : the Official Journal of the Microcirculatory Society, Inc·Wei WangLih Kuo
May 1, 1997·Prostaglandins, Leukotrienes, and Essential Fatty Acids·R J KarmanC M Hart
May 28, 2005·The Journal of Surgical Research·Rakesh SafayaChangyi Chen
Jun 1, 2014·Free Radical Biology & Medicine·Brian E Sansbury, Bradford G Hill
Sep 20, 2000·Molecular Genetics and Metabolism·X L Wang, J Wang
Mar 18, 2000·The Journal of Surgical Research·T H Pohlman, J M Harlan
Apr 26, 2005·Journal of Ethnopharmacology·Ming Hao YinHo Sub Lee
Jan 16, 1998·Prostaglandins, Leukotrienes, and Essential Fatty Acids·K R Bruckdorfer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.